A Prospective, Randomized, Multicenter Study Evaluating the Safety and Efficacy of Two Dosing Regimens of Daclizumab Compared to No Antibody Induction in Simultaneous Kidney–Pancreas Transplantation: Results at 3 Years
Year: 2005
Type: article
Study design: Clinical Trial
Source: Transplantation Proceedings
Authors: R.J. Stratta, R.R. Alloway, A. Lo, E.E. Hodge
Language: English
Subfield: Transplantation
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2115522596
